Familial Hypercholesterolemia in pregnancy and newborns study
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how familial hypercholesterolemia (a genetic condition that causes high cholesterol) affects mothers and their newborns. It aims to learn more about cholesterol levels during pregnancy and the baby's first week of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and pregnant (at least 12 weeks along).
- You or your partner has been diagnosed with familial hypercholesterolemia (HeFH or HoFH).
- You are willing to sign a consent form and follow study steps.
- You agree to have your baby's blood collected (a few drops from a heel prick) within the first week after birth.
- Your baby does not have any serious medical conditions that would prevent the blood collection or require intensive care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on people with familial hypercholesterolemia (FH), an inherited condition that causes very high cholesterol. It aims to better understand and manage severe cholesterol problems that raise heart risk, especially in families.
This study looks for family members of people with familial hypercholesterolemia (FH), a genetic condition that causes very high cholesterol. The goal is to help find and screen relatives who may also have FH, so they can get earlier care.
This trial aims to identify kids and teens who may have inherited high cholesterol (especially LDL) and may be at higher risk for early heart artery disease. It may help families learn about their risk and ensure the right follow-up and treatment plan.
This study looks at children who may have inherited high cholesterol, especially when one parent is affected. It may help doctors detect the condition earlier and understand how it runs in families.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This registry collects information from people with inherited high cholesterol to better understand the condition and care needs. You may be invited to share blood and medical test results, especially your cholesterol and related health history.
Hear when a new Heterozygous Familial Hypercholesterolemia (HeFH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.